For: | Providência R, Paiva L, Barra S. Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives. World J Cardiol 2012; 4(6): 195-200 [PMID: 22761972 DOI: 10.4330/wjc.v4.i6.195] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v4/i6/195.htm |
Number | Citing Articles |
1 |
Mahmoud Kamel Ahmed, Walaa Fared Abdelazez, Mofeed Ahmad Nasif. Assessment of left atrium mechanical function by deformation imaging in atrial fibrillation and its correlation with CHA2DS2-VASc risk score. The Egyptian Heart Journal 2015; 67(3): 209 doi: 10.1016/j.ehj.2014.08.001
|
2 |
W. El Borgi, S. Romdhane, W. Sdiri, S. Longo, R. Hafsia, M.R. Boujnah. Intérêt du dosage des d-dimères dans la fibrillation atriale non valvulaire. Première série prospective tunisienne. Annales de Cardiologie et d'Angéiologie 2015; 64(4): 279 doi: 10.1016/j.ancard.2015.01.003
|
3 |
J. A. Vílchez, V. Roldán, D. Hernández-Romero, M. Valdés, G. Y. H. Lip, F. Marín. Biomarkers in atrial fibrillation: an overview. International Journal of Clinical Practice 2014; 68(4): 434 doi: 10.1111/ijcp.12304
|
4 |
Ana I. Rodríguez-Serrano, María A. Esteve-Pastor, Diana Hernández-Romero, Mariano Valdés, Vanessa Roldán, Francisco Marín. Biomarkers in Cardiovascular Disease. 2015; : 1 doi: 10.1007/978-94-007-7741-5_36-1
|
5 |
Sarah C.W. Marott, Sune F. Nielsen, Marianne Benn, Børge G. Nordestgaard. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study. European Heart Journal 2014; 35(18): 1205 doi: 10.1093/eurheartj/eht507
|
6 |
Talal Moukabary, Mario D. Gonzalez. Management of Atrial Fibrillation. Medical Clinics of North America 2015; 99(4): 781 doi: 10.1016/j.mcna.2015.02.007
|
7 |
Ana I. Rodríguez-Serrano, María A. Esteve-Pastor, Diana Hernández-Romero, Mariano Valdés, Vanessa Roldán, Francisco Marín. Biomarkers in Cardiovascular Disease. 2016; : 507 doi: 10.1007/978-94-007-7678-4_36
|